Cited by 126Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and TreatmentsImmune Response and Inflammation

Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis

Open access
Shimoda, Shinji, Harada, Kenichi, Niiro, Hiroaki, Shirabe, Ken, Taketomi, Akinobu, Maehara, Yoshihiko, Tsuneyama, Koichi, Nakanuma, Yasuni +4 more·2011·Hepatology

Abstract

Primary biliary cirrhosis (PBC) is characterized by chronic nonsuppurative destructive cholangitis (CNSDC) associated with destruction of small bile ducts. Although there have been significant advances in the dissection of the adaptive immune response against the mitochondrial autoantigens, there are increasing data that suggest a contribution of innate immune mechanisms in inducing chronic biliary pathology. We have taken advantage of our ability to isolate subpopulations of liver mononuclear cells (LMC) and examined herein the role of Toll-like receptors (TLRs), their ligands, and natural killer (NK) cells in modulating cytotoxic activity against biliary epithelial cells (BECs). In particular, we demonstrate that Toll-like receptor 4 ligand (TLR4-L)-stimulated NK cells destroy autologous BECs in the presence of interferon alpha (IFN-α) synthesized by TLR 3 ligand (TLR3-L)-stimulated monocytes (Mo). Indeed, IFN-α production by hepatic Mo is significantly increased in patients with PBC compared to disease controls. There were also marked increases in the cytotoxic activity of hepatic NK cells from PBC patients compared to NK cells from controls but only when the NK cells were prepared following ligation of both TLR3-L- and TLR4-L-stimulated LMC. These functional data are supported by the immunohistochemical observation of an increased presence of CD56-positive NK cells scattered around destroyed small bile ducts more frequently in liver tissues from PBC patients than controls. Conclusion: These data highlight critical differences in the varied roles of Mo and NK cells following TLR3-L and TLR4-L stimulation. (HEPATOLOGY 2011.)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.24194

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Expansion of innate immune cells, including natural killer cells and myeloid-derived suppressor cells, has been observed in patients with primary biliary cholangitis.

    “including natural killer cells and myeloid-derived suppressor cells, has been observed in patients with primary biliary cholangitis.[41][42][43][44]”

    From Primary biliary cholangitis. (2024) · cites this paper as [42]

    The Abstract (page unavailable) reports an increased presence of CD56-positive natural killer cells around destroyed small bile ducts in liver tissue from PBC patients compared with controls. It does not report expansion of myeloid-derived suppressor cells, so only the natural killer cell portion is supported. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Upon TLR stimulation, NK cells can induce BEC apoptosis.

    “Furthermore, upon TLR stimulation NK cells can induce BEC apoptosis(268).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 37

  1. [1]Gershwin ME Ansari AA Mackay IR Nakanuma Y Nishio A Rowley MJ Coppel RL Primary biliary cirrhosis: an orchestrated immune response against epithelial cells Immunol Rev 2000 174 210 225 10807518
  2. [2]Kaplan MM Gershwin ME Primary biliary cirrhosis N Engl J Med 2005 353 1261 1273 16177252
  3. [5]Lleo A Bowlus C Yang G-X Invernizzi P Podda M Van de Water J Ansari A Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis Hepatology 2010 52 987 998 20568301 PMC2932809
  4. [6]Van de Water J Ishibashi H Coppel RL Gershwin ME Molecular mimicry and primary biliary cirrhosis: premises not promises Hepatology 2001 33 771 775 11283838
  5. [7]Kamihira T Shimoda S Nakamura M Yokoyama T Takii Y Kawano A Handa M Biliary epithelial cells regulate autoreactive T cells: implications for biliary-specific diseases Hepatology 2005 41 151 159 15619239
  6. [8]Shimoda S Harada K Niiro H Taketomi A Maehara Y Tsuneyama K Kikuchi K CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis Hepatology 2010 51 567 575 19908209 PMC2911959
  7. [9]Shimoda S Van de Water J Ansari A Nakamura M Ishibashi H Coppel RL Lake J Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis J Clin Invest 1998 102 1831 1840 9819369 PMC509133
  8. [10]Kawano A Shimoda S Kamihira T Ishikawa F Niiro H Soejima Y Taketomi A Peripheral tolerance and the qualitative characteristics of autoreactive T cell clones in primary biliary cirrhosis J Immunol 2007 179 3315 3324 17709548
  9. [11]Shimoda S Ishikawa F Kamihira T Komori A Niiro H Baba E Harada K Autoreactive T-cell responses in primary biliary cirrhosis are proinflammatory whereas those of controls are regulatory Gastroenterology 2006 131 606 618 16890612
  10. [13]Walzer T Dalod M Robbins SH Zitvogel L Vivier E Natural-killer cells and dendritic cells: “l’union fait la force” Blood 2005 106 2252 2258 15933055
  11. [14]Goodnow CC Multistep pathogenesis of autoimmune disease Cell 2007 130 25 35 17632054
  12. [15]Palmer MT Weaver CT Autoimmunity: increasing suspects in the CD4+ T cell lineup Nat Immunol 2010 11 36 40 20016508
  13. [16]Gershwin ME Mackay IR The causes of primary biliary cirrhosis: Convenient and inconvenient truths Hepatology 2008 47 737 745 18098322
  14. [17]Strutt TM McKinstry KK Dibble JP Winchell C Kuang Y Curtis JD Huston G Memory CD4+ T cells induce innate responses independently of pathogen Nat Med 2010 16 558 564 551p following 564 20436484 PMC2927232
  15. [18]Lanier LL Up on the tightrope: natural killer cell activation and inhibition Nat Immunol 2008 9 495 502 18425106 PMC2669298
  16. [19]Tu Z Bozorgzadeh A Pierce RH Kurtis J Crispe IN Orloff MS TLR-dependent cross talk between human Kupffer cells and NK cells J Exp Med 2008 205 233 244 18195076 PMC2234385
  17. [20]Hart OM Athie-Morales V O’Connor GM Gardiner CM TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production J Immunol 2005 175 1636 1642 16034103
  18. [21]Stegmann KA Bjorkstrom NK Veber H Ciesek S Riese P Wiegand J Hadem J Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection Gastroenterology 2010 138 1885 1897 20334827
  19. [22]Oliviero B Varchetta S Paudice E Michelone G Zaramella M Mavilio D De Filippi F Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections Gastroenterology 2009 137 1151 1160 1160 e1151 1157 19470388
  20. [23]Takayama T Kamada N Chinen H Okamoto S Kitazume M Chang J Matuzaki Y Imbalance of NKp44+NKp46- and NKp44-NKp46+ natural killer cells in the intestinal mucosa of patients with Crohn’s disease Gastroenterology 2010 139 882 892 20638936
  21. [24]Gur C Porgador A Elboim M Gazit R Mizrahi S Stern-Ginossar N Achdout H The activating receptor NKp46 is essential for the development of type 1 diabetes Nat Immunol 2010 11 121 128 20023661
  22. [25]Gao B Natural killer group 2 member D, its ligands, and liver disease: good or bad? Hepatology 2010 51 8 11 20034045 PMC2799539
  23. [27]Takii Y Nakamura M Ito M Yokoyama T Komori A Shimizu-Yoshida Y Nakao R Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis Lab Invest 2005 85 908 920 15856047
  24. [28]Liu YJ IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors Annu Rev Immunol 2005 23 275 306 15771572
  25. [29]Hopf U Moller B Stemerowicz R Lobeck H Rodloff A Freudenberg M Galanos C Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis Lancet 1989 2 1419 1422 2574361
  26. [30]Butler P Valle F Hamilton-Miller JM Brumfitt W Baum H Burroughs AK M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria J Hepatol 1993 17 408 414 8315267
  27. [31]Banchereau J Pascual V Type I interferon in systemic lupus erythematosus and other autoimmune diseases Immunity 2006 25 383 392 16979570
  28. [32]Croft M The role of TNF superfamily members in T-cell function and diseases Nat Rev Immunol 2009 9 271 285 19319144 PMC2737409
  29. [33]Luger D Silver PB Tang J Cua D Chen Z Iwakura Y Bowman EP Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category J Exp Med 2008 205 799 810 18391061 PMC2292220
  30. [34]Baccala R Hoebe K Kono DH Beutler B Theofilopoulos AN TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity Nat Med 2007 13 543 551 17479100
  31. [35]Walter U Santamaria P CD8+ T cells in autoimmunity Curr Opin Immunol 2005 17 624 631 16226438
  32. [36]Rajagopal D Paturel C Morel Y Uematsu S Akira S Diebold SS Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists Blood 2010 115 1949 1957 20065291 PMC2837337
  33. [37]Stary G Klein I Kohlhofer S Koszik F Scherzer T Mullauer L Quendler H Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients Blood 2009 114 3854 3863 19690337
  34. [38]Mellor AL Munn DH IDO expression by dendritic cells: tolerance and tryptophan catabolism Nat Rev Immunol 2004 4 762 774 15459668
  35. [39]Sozzani S Vermi W Del Prete A Facchetti F Trafficking properties of plasmacytoid dendritic cells in health and disease Trends in Immunology 2010 31 270 277 20579936
  36. [40]Isse K Harada K Zen Y Kamihira T Shimoda S Harada M Nakanuma Y Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts Hepatology 2005 41 506 516 15726664
  37. [41]Pallandre JR Krzewski K Bedel R Ryffel B Caignard A Rohrlich PS Pivot X Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation Blood 2008 112 4420 4424 18682600 PMC2597118

Cited by

Sorted by citations

Authors
Shimoda, S., Harada, K., Niiro, H., Shirabe, K., Taketomi, A., Maehara, Y., Tsuneyama, K., Nakanuma, Y., Leung, P., Ansari, A. A., Gershwin, E. M., & Akashi, K.
Affiliations
  • Kyushu University (JP)
  • Kanazawa University (JP)
  • University of Toyama (JP)
  • University of California, Davis (US)
  • Emory University (US)
Corresponding author
Shimoda, Shinji
Venue
Hepatology
Published
2011-04
Volume
53
Issue
4
Pages
1270-1281
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2150724838
Cited by
126
References
4
Citations by year
2026: 1 · 2025: 6 · 2024: 6 · 2023: 5 · 2022: 7 · 2021: 4 · 2020: 6 · 2019: 7 · 2018: 7 · 2017: 11 · 2016: 7 · 2015: 14 · 2014: 10 · 2013: 20 · 2012: 11
FWCI
9.15
Type
journal article
Language
en
Open access
Locations
  • Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Japan Society for the Promotion of Science (21591267, 21590433)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R37DK039588, R01DK039588)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
primary biliary cirrhosis, Toll-like receptors, natural killer cells, TLR4, TLR3, interferon-alpha, monocytes, bile duct destruction, cholangiocytes, innate immunity, liver mononuclear cells, cytotoxicity
MeSH terms
Bile Ducts, Epithelial Cells, Humans, Immunity, Innate, Killer Cells, Natural, Lipopolysaccharides, Liver, Liver Cirrhosis, Biliary, Monocytes, Poly I-C, Interferon-alpha, Toll-Like Receptors, Toll-Like Receptor 3, Toll-Like Receptor 4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review